Filing Flows › Innovate (VATE) › Life Sciences revenue
Innovate (VATE) Life Sciences revenue by quarter
Innovate's Life Sciences revenue was $2.2M in Q2 2026 (second quarter 2026), +38% from Q1 2026. Over the last 7 quarters it ranged from $1.6M (Q1 2026) to $4.1M (Q4 2024).
| Quarter | Life Sciences revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.2M | +38% | -31% |
| Q1 2026 | $1.6M | -48% | -48% |
| Q4 2025 | $3.1M | 0% | -24% |
| Q3 2025 | $3.1M | -3% | — |
| Q2 2025 | $3.2M | +3% | — |
| Q1 2025 | $3.1M | -24% | — |
| Q4 2024 | $4.1M | — | — |
Q2 2026 at a glance
Innovate, Q2 2026: revenue $422M (+74% year over year), operating margin 8.2%, net earnings $10.7M, operating cash flow −$24.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innovate's Life Sciences revenue?
Innovate's Life Sciences revenue was $2.2M in Q2 2026 (second quarter 2026), +38% from Q1 2026.
How has Innovate's Life Sciences revenue changed?
Over the last 7 quarters it ranged from $1.6M (Q1 2026) to $4.1M (Q4 2024).